Tiziana Life Sciences PLC (LON:TILS – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 58.50 ($0.73) and traded as low as GBX 45 ($0.57). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.73), with a volume of 297,127 shares traded.
Tiziana Life Sciences Price Performance
The stock has a fifty day moving average of GBX 58.50 and a 200 day moving average of GBX 58.50. The firm has a market capitalization of £113.85 million and a P/E ratio of -3.59. The company has a debt-to-equity ratio of 2.36, a current ratio of 6.54 and a quick ratio of 6.41.
Tiziana Life Sciences Company Profile
Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.
Further Reading
- Five stocks we like better than Tiziana Life Sciences
- How to Invest in the FAANG Stocks
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Trading Halts Explained
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- How to buy stock: A step-by-step guide for beginners
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
